Company Description. BioCytics is a biotechnology company developing a personalized immuno-oncology platform focused on novel cellular therapies for cancer. Incubated within the Carolina BioOncology Institute, a leading independent Phase I clinical trial site, BioCytics benefits from proximity to clinical research while operating independently. The company offers contract R&D services, wet lab space, and conducts translational research supported ...
